Thomas Clausen, Dr. Med, University of Oslo
40 ára afmælisráðstefna SÁÁ: Developments in prescription opioids in the Nordics and Norway and trends in overdose deaths Thomas Clausen Professor, Dr. Med, University of Oslo Norwegian Centre for Addiction Research (SERAF), University of Oslo, Norway Thomas Clausen is a professor and head of research centre at the Norwegian Centre for Addiction Research, SERAF, University of …Read more »
Nora D. Volkow, Director of the NIDA
40 ára afmælisráðstefna SÁÁ: Addiction Is a Chronic Brain Disease – What We Know Today Nora D. Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Abstract Addiction is a disorder that involves complex interactions between genes, development and the social environment. Studies employing neuroimaging technology paired …Read more »
Valgerður Rúnarsdóttir, Medical Director at SÁÁ
40 ára afmælisráðstefna SÁÁ: Opioid addiction in Iceland SÁÁ Valgerður Rúnarsdóttir, MD, Medical Director at SÁÁ Abstract In Iceland, the opioid addiction problem is because of prescription opioid almost solely. Heroin is not generally found on the black market but prescription tablets are. Prescription drugs are part of the addiction problem in general, like in other …Read more »
George Woody, Perelman School of Medicine
40 ára afmælisráðstefna SÁÁ: International research on addiction treatment George Woody MD, Professor, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania Abstract The HIV epidemic generated a high level of interest in addiction research, particularly treatment research, due to it association with injecting drug use, and drug use and unprotected sex. The result …Read more »
Nora D. Volkow, Director of NIDA
40 ára afmælisráðstefna SÁÁ: Cannabis and society – can science guide public policies? Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. …Read more »
Arndís Sue Ching Löve, PhD student MS Pharm
40 ára afmælisráðstefna SÁÁ: Estimation of community drug abuse in the Reykjavík metropolitan area by wastewater analysis Arndís Sue Ching Löve, PhD student MS Pharm Abstract Introduction: Drug abuse has been a matter of concern worldwide due to the risks these substances pose to human health, and their connection to crime. Sewage epidemiology is a methodology used …Read more »
Gregory Bunt, MD, FISAM
40 ára afmælisráðstefna SÁÁ: Medicinal Marijuana, Policy and Physician Gregory Bunt, MD FISAM, President, International Society of Addiction Medicine Diplomate, American Board of Psychiatry and Neurology, Clinical Assistant Professor of Psychiatry, NYU School of Medicine, New York, NY Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry …Read more »
David R. Gastfriend, MD, DFASAM
40 ára afmælisráðstefna SÁÁ: What We Know & Don’t Know About Technology for Assessment, Pharmacotherapy and Contingency Management? David R. Gastfriend, MD, DFASAM, Chief Architect, CONTINUUM – The ASAM Criteria Decision Engine™; Chief Medical Officer & Co-Founder, DynamiCare Health, Inc.; Scientific Advisor, Treatment Research Institute Abstract Technology can enhance healthcare access and quality. Academic-entrepreneurial partnerships have …Read more »
Kaarlo Simojoki MD, PhD
40 ára afmælisráðstefna SÁÁ: New patterns in addiction in Finland and challenges for the addiction treatment system Kaarlo Simojoki MD, PhD, Chief Medical Officer of the A-Clinic Foundation Languages: Finnish German English Swedish Training: 1999 M.D. at University of Helsinki 2006 Specialist in Addiction Medicine 2013 Ph.D at University of Helsinki Current position: Medical Director …Read more »
